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Propolis is believed to have antimicrobial, anti-inflammatory and immunostimulating activities.  The objective of this
study was to investigate the antibacterial activity of ethanol extract propolis (EEP) of Trigona spp. from Bukittinggi West
Sumatera against Campylobacter spp. Antibacterial activity of  the EEP was measured by disc diffusion method. The
compound groups of the propolis were also analyzed on the existence of alkaloids, flavonoids, saphonins, tannins,
steroids, and terpenoids. This study revealed that the EEP of Trigona spp.  shows an antibacterial activity on Campylobacter
spp. The compound groups detected in the EEP were flavonoids and tannins, suggesting that the antibacterial activity of
propolis of Trigona spp.  may be due to these compounds.
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INTRODUCTION
Propolis (bee glue) is a sticky dark-colored material that
honeybees collect from living plants, mix with wax and use in
construction and adaptation of their nests (Bankova et al.
2000). Bees use propolis not only as a building material, but
also as a means of maintaining low levels of bacterial and
fungal concentrations in the hive. The action against
microorganisms is an essential characteristic of propolis and
it has been used by human beings since ancient times for its
pharmaceutical properties. Propolis possesses antibacterial,
antifungal, antiviral properties, and many other beneficial
biological activities: anti-inflammatory, antiulcer, local
anesthetic, hepatic-protective, antitumor, and immune-
stimulating. For this reason, propolis is widely used as a
popular remedy in folk medicine, in apitherapy, as a constituent
of “biocosmetics”, “health food”, and for numerous further
purposes (Bankova et al. 2000).
Generally propolis is obtained from honeybee Apis spp.
One of the other bees collecting less honey and more propolis
is Trigona spp., a member of stingless bees. Hasan (2006)
found that propolis from Trigona spp. was effective against
Bacillus subtilis, Staphilococcus aureus, and Eschericia coli.
Sabir (2005) showed that flavonoids Trigona sp. propolis
inhibited Streptococcus mutans growth.
Campylobacter is a type of pathogenic bacteria found in
the intestines of many wild and domestic animals. The bacteria
are passed in their feces, which can lead to infection to humans
via contaminated food, meats, water taken from contaminated
sources (streams or rivers near where animals graze), and milk
products that have not been pasteurized. Once inside the
human digestive system, Campylobacter infects and attacks
the lining of both the small and large intestines. Infection
with a Campylobacter species is one of the most common
causes of human bacterial gastroenteritis (Moore et al. 2005).
Thermo-tolerant Campylobacter, especially Campylobacter
jejuni, belongs to the most frequent etiological agents of food-
borne diseases, the number of which has been increasing
recently worldwide (Allos 2001).
The disorder usually recedes without antimicrobial
therapy, however in more serious cases treatment is necessary
(McDermott et al. 2005). The drug of choice is a macrolide
(e.g., erythromycin) for the treatment of enteric campylobacter
infections after microbiological diagnosis. However, for the
empiric treatment of adults with suspected bacterial
gastroenteritis, the drug of choice typically includes a
fluoroquinolone (e.g., ciprofloxacin) because of their activity
against almost all enteric bacterial pathogens (Allos 2001;
Engberg et al. 2004).
However, it has been shown that in the course of previous
years there have been selected strains of Campylobacter spp.
resistant to antimicrobial agents, especially to
fluoroquinolones (Thakur & Gebreyes 2005; Larkin et al. 2006).
Antimicrobial drug resistance in Campylobacter infections,
in particular to quinolones, has increased dramatically in many
countries (Engberg et al. 2001).
Based on the reasons mentioned above, it is considered
to be important to search for new antibacterial agents that
can effectively inhibit Campylobacter growth. Little data are
currently reported on the activity of propolis against
Campylobacter. We suggest that propolis from Trigona spp.
may be one of new natural antimicrobial agents which can be
used to treat Campylobacter infection. Therefore, the main
objective of this research was to identify antibacterial activity
of Trigona spp. propolis against Campylobacter spp.
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MATERIALS  AND  METHODS
Sample Collections. Trigona spp. hive as propolis
resource was collected from Bukittinggi West Sumatera during
the dry season (July-August). This location resides in
100.210-100.250 oLE and 00.760-00.190 o PS, altitude 909-941 m
above sea water, temperature 16.10-24.90 oC. This location
has rainfall at 2.381 mm per year and humidity between 82.0-
90.8% (PEMKOT Bukittinggi 2007).
Extraction of Propolis. The hive was cut into small pieces,
grounded and extracted with 70% ethanol (1:5 w/v) in a shaker
(EYELA, Japan) at speed of 130 rpm, and at room temperature
for 14 days. The extract solution was then filtered through a
filter paper, and then the ethanol was evaporated using freeze-
drier to obtain ethanol extract of propolis (EEP) free of solvent
(Hasan 2006).
Preparation of Inoculums. Campylobacter was cultured
for 24 h at 42 oC in a liquid medium (campylobacter base,
DIFCO) and used as inoculums. The turbidity of the
suspension was adjusted to 0.5 with McFarland turbidity
standard.
Antibacterial Activity. Antibacterial activity of EEP was
investigated by the disc diffusion method (Andrews 2001).
The bacterial screening was performed by using
Campylobacter agar base (DIFCO) and Campylobacter
supplement. Sterile paper discs (Whatman # 4 paper, 6 mm
diameter) were loaded with 15 ìl of propolis extract dilutions
(16.7, 8.3, 4.1, 2.0, 1.0, 0.2, 0.1, and 0.06% w/w). Six discs were
put on each petridish cultured with Campylobacter. The
ampicillin (100 ug/ml) and commercial propolis were used as
positive controls, and the solvent was used as a negative
control. Plates were incubated at 42 oC for 48 h in an anaerobic
jar flowed with CO2 and N2. Inhibitory zone diameter was
measured with a calliper each treathment was performed in
triplicates. The data were subjected to analysis of variance
using general liner model procedure of SPSS with α 0.05.
Compound Groups Test. The EEP was subjected to
phytochemical analysis for the presence of compound groups
such as flavonoids, alkaloids, terpenoids, steroids, saphonins,
and tannins, based on Harborne (1996). Flavonoids were
identified by using solution containing magnesium, amyl
alcohol and concentrate hydrochloride acid. Alkaloids were
identified by using Dragendorff solution, whereas steroids
and terpenoids were tested by using Lieberman-Buchard
solution. The presence of tannins was identified by using
ferrichloride solution, and saphonins were identified by using
foam forming test in hot water.
RESULTS
The EEP obtained was very sticky with dark brown colored.
The average of extraction yield was 24.66% (w/w). The EEP
still contained ethanol in very low concentration (0.05%). The
diameters of bacterial growth inhibited by different
concentration of EEP and controls were shown in Figure 1.
The results showed that at a concentration of 16.67%, EEP
was more effective than the commercial propolis, but less
active compared to ampicillin (100 ppm) on Campylobacter
spp. growth (Figure 2). The solvent (negative control) did not
Propolis x
Ampicillin
1.04%
2.08%
4.17%
8.33%
16.67%
Figure 2. EEP tested on plate cultured with Campylobacter. 1.04%,
16.67% are EEP in concentration of 1.04% (w/w), 16.67%
(w/w). Ampicillin means ampicillin solution in water at
concentration 100 ppm. Propolis x is commercial propolis
undilution.
Figure 1. The means of diameters (mm) of bacterial growth inhibited by different concentrations of Trigona spp. propolis and other controls.
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show any inhibitory effect on the tested bacteria. Among the
series concentration of EEP tested, the least concentration
that still showed inhibitory effect was 2.08% (two replicates),
and 1.04 (one sample), thus the average of minimum inhibition
concentration (MIC) was 1.73% (w/w). The compounds
groups identified in Trigona spp. propolis are flavonoids and
tannins (Table 1).
fluoroquinolones (Thakur & Gebreyes 2005; Larkin et al. 2006),
whereas the complexity and synergistic effects of compounds
in propolis make bacteria difficult to build tolerant for propolis
(Mizrahi & Lensky 1997). Secondly, propolis is a relatively
non toxic drug (Nikulin et al. 1979).
The compound analysis showed the propolis of Trigona
spp. was rich in polyphenol compounds, i.e. flavonoids and
tannins. These results confirm previous studies reporting that
caffeic acids, flavonoids and phenolic esters were the main
biologically active compounds in propolis (Kujumgiev et al.
1993; Park et al. 1998; Marcucci et al. 2001; Kartal et al. 2003).
However, their biological effects cannot be attributed solely
to these components since the chemical composition of
propolis is complex. Some authors attributed the complex
composition of propolis as a reason for its antimicrobial
activity, and some mechanisms of action have been proposed
(Simuth et al. 1986; Strehl et al. 1994; Takaishi & Schilcher
1994; Mirzoeva et al. 1997; Park et al. 1998). The antimicrobial
properties of propolis related to the synergistic effect of its
compounds (Santos et al. 2002). The propolis affects the
cytoplasmic membrane and inhibits bacterial motility as well
as enzyme activity (Mirzoeva et al. 1997). Propolis exhibits
bacteriostatic activity against different bacterial genera and
can be bactericidal in a high concentration (Mirzoeva et al.
1997; Drago et al. 2000). The mechanism of action of
antibacterial properties of flavonoid is by interfering bacterial
cell wall permeability, microsome, and lysosome as a result of
its interaction with bacterial DNA (Wilson & Gisvold 1982;
Bryan 1982). This mechanism of action differs from that of
ampicillin as the standard antibiotic. Ampicillin inhibits
bacterial cell wall synthesis by binding to one or more of the
penicillin binding proteins (PBPs); which in turn inhibits the
final transpeptidation step of peptidoglycan synthesis in
bacterial cell walls, thus inhibiting cell wall biosynthesis.
Bacteria eventually lyse due to ongoing activity of cell wall
autolytic enzymes (autolysins and murein hydrolases) while
cell wall assembly is arrested (Donowitz & Mandell 1988).
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